Home » Topics » Regulatory » EMA

EMA
RSS

COMP issues opinion on orphan drug of CYT-387 in myelofibrosis

June 2, 2011

EMA to review Gentium's MAA for defibrotide under accelerated assessment

June 2, 2011

EMA accepts Pfizer's regulatory filing for axitinib in renal cell carcinoma

June 2, 2011

EMA and Health Canada recommend revaccination with Ixiaro vaccine due to batch recall

May 30, 2011

EMA accepts for review Savient Pharmaceuticals' MAA for Krystexxa

May 30, 2011

NeuroSearch to conduct phase III confirmatory trial of Huntexil

May 26, 2011

CHMP issues negative trend vote on Bronchitol for cystic fibrosis

May 25, 2011

EMA's CHMP recommends label extension for tocilizumab

May 24, 2011

EMA committee recommends accelerated approval of Victrelis for hepatitis C genotype 1

May 23, 2011

CHMP recommends approval of Vibativ for nosocomial pneumonia caused by MRSA

May 23, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
In the clinic for April 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Abbott, Agenus, Astrazeneca, Briacell, Clearmind, Greenwich, Intodna,...